Dr. Richard Carvajal, MD

Dr. Richard Carvajal, MD

Save
Hematology  |  
Male  |  
44 y/o
(9)

Accepting new patients

As the Director of Experimental Therapeutics and Director of the Melanoma Service at Columbia University Medical Center, Dr. Carvajal is focused on the development of novel therapies for patients with melanoma and other cancers, with the overall objective of controlling and curing these diseases. To achieve this goal, he has used our increasing knowledge of the underlying biology of cancer to rapidly integrate this knowledge, novel therapeutic agents, and efficient trial design in order to improve the outcomes of cancer patients everywhere. Working closely with the laboratory scientists, the group is using the techniques of molecular biology to identify specific proteins, genes, or other molecules that influence the growth of each person's cancer, with the goal of selecting the most promising therapies for individual patients. Dr. Carvajal's melanoma research has included the study and treatment of uncommon clinical and molecular subsets of melanoma such as melanomas arising from the eye (uveal melanomas), from the mucosal surfaces of the body (mucosal melanomas), and from the palms of the hands, soles of the feet, or under the fingernails (acral melanomas). Although these tumors arise from pigment cells of the body just as do the more common melanomas that arise from the skin (cutaneous melanomas), they are clinically and biologically distinct from cutaneous disease. Once metastatic (that is, spread from where it originally began to other sites in the body), these diseases have proven to be difficult to treat. In an advance that helped to launch a new era of personalized medicine in melanoma therapy, Dr. Carvajal has led a clinical trial of imatinib (Gleevec) in patients with melanoma characterized by the presence of a mutation in a gene called KIT. While this mutation is rare in cutaneous melanoma, it is found in about 20% of mucosal and acral melanomas. Based in part on the positive results of this trial, where long-lasting tumor responses were observed in patients with these diseases, the use of imatinib in melanomas harboring KIT mutations was added to the National Comprehensive Cancer Network guidelines for the treatment of melanoma. Uveal melanoma is characterized by mutations in genes called GNAQ and GNA11 that lead to activation of a growth pathway called the MAPK pathway. Before 2013, there were no effective treatments for metastatic disease; however, another trial that Dr. Carvajal has developed and conducted identified selumetinib, a medicine that blocks the MAPK pathway, as the first effective treatment for patients with advanced uveal melanoma. Dr. Carvajal's research has been supported by the National Cancer Institute, the Food and Drug Administration, the Conquer Cancer Foundation, the Melanoma Research Alliance, the Melanoma Research Foundation, the Empire Clinical Research Investigator Program, and the generous philanthropic support of our patients and their families. He has authored or co- authored more than 50 peer-reviewed manuscripts, books, and book chapters. In addition to Dr. Carvajal's work at Columbia University Medical Center, he serves as the co-chair of the International Rare Cancer Initiative Uveal Melanoma working group, a joint initiative between the National Cancer Institute, the European Organization for Research and Treatment of Cancer, and the Cancer Research UK to enhance international collaboration in the conduct of clinical trials for uveal melanoma.

Columbia University Medical Center Division of Hematology/Oncology

161 Fort Washington Ave Fl 9

New York, NY 10032
Get Directions

Accepted insurance

  • Aetna
  • Amalgamated Clothing & Textile Workers Union
  • Amerihealth
  • Blue Cross Blue Shield
  • Cigna
  • Commercial Insurance Company
  • EBS-RMSCO
  • EmblemHealth
  • Empire Blue Cross Blue Shield
  • Fidelis Care
  • Group Health Cooperative
  • Humana
  • Locals (any local)
  • MultiPlan

Learn about Dr. Carvajal

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you

Top Care Areas

new

See how frequently Dr. Carvajal performs your care needs compared to other doctors.

Melanoma
high
more than 89% of peers
Secondary Malignancies
normal
more than 73% of peers
Lung Cancer
normal
more than 71% of peers

Dr. Carvajal's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

We're trying something new with Top Care Areas.Was it helpful for you?YesNo

Care Philosophy

This content was provided by Dr. Carvajal "We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person. "
2

Specialties

  • Hematology
  • Medical Oncology
2

Board Certifications

  • Hematology
    Accredited by: American Board of Internal Medicine*
  • Medical Oncology
    Accredited by: American Board of Internal Medicine*
99

Conditions Treated

  • Adrenal Gland Cancer
  • All Lymphoma
  • Anal Disorders
  • Anal and Rectal Cancer
  • Anemia
  • Antiphospholipid Syndrome (APS)
  • Autoimmune Diseases
  • Basal Cell Carcinoma
  • Bile Duct Cancer
  • Bladder Cancer
  • Bleeding Disorders
  • Blood Disorders
  • Bone Cancer
  • Bone Disorders
  • Brain Cancer
  • Brain Disorders
  • Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Breast Cancer
  • Breast Diseases
  • Cancer
  • Cervical Cancer
  • Coagulation Disorders (incl. Hemophilia)
  • Colorectal Cancer
  • Deep Vein Thrombosis (DVT)
  • ENT Cancer
  • Esophageal Cancer
  • Esophageal Diseases
  • Eye Cancer
  • Fallopian Tube Cancer
  • Gallbladder Cancer
  • Gallbladder and Biliary Tract Cancer
  • Gastrointestinal Diseases
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hemophilia
  • Hemophilia A
  • Hodgkin's Disease
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Kidney Cancer
  • Laryngeal Cancer
  • Larynx Conditions
  • Leukocytosis
  • Lip Cancer
  • Liver Cancer
  • Lung Cancer
  • Lung Neoplasms, Not Specified as Malignant
  • Lymphosarcoma
  • Malignant Histiocytosis
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Mediastinal Tumors, Malignant
  • Mediastinal Tumors, Not Specified as Malignant
  • Melanoma
  • Meningiomas
  • Merkel Cell Carcinoma
  • Myelodysplastic Syndromes
  • Myeloma
  • Myeloproliferative Disorders
  • Neuroendocrine Tumors
  • Neutropenia
  • Nodular Lymphoma
  • Non-Hodgkin's Lymphoma
  • Oral Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pancytopenia
  • Pleural Cancer
  • Polycythemia Rubra Vera
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Prostate Cancer
  • Pulmonary Disease
  • Retinoblastoma
  • Salivary Gland Cancer
  • Secondary Hypertension
  • Secondary Malignancies
  • Skin Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Squamous Cell Carcinoma
  • Stomach Cancer
  • Stomach Diseases
  • Stomach and Small Intestine Cancer
  • Thalassemia
  • Throat Cancer (Hypopharyngeal)
  • Throat Cancer (Nasopharyngeal)
  • Thrombosis
  • Thyroid Cancer
  • Tongue Cancer
  • Tonsil Cancer
  • Urinary Disorders
  • Uterine Cancer
  • Uterine Diseases
  • Vaginal Cancer
  • Vascular Disease
  • Venous Embolism and Thrombosis
  • Vertebral Column Tumors
  • Vulvar Cancer

More

Read More
4

Procedures

  • Bone Marrow Biopsy
  • Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
  • Immunotherapy
  • Thoracentesis

Background Check

0 Malpractice Claims

No malpractice history found for New York.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • New York University School Of Medicine
    Medical School | Graduated 2000
  • University Of Michigan Hospitals
    Residency Hospital | Completed 2003
  • Memorial Sloan Kettering
    Fellowship Hospital | Completed 2007

Awards & Recognition

Awards & Honors
  • Healthgrades Honor Roll
Media & Publications

Dr. Carvajal has no media or publications listed.

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Carvajal does not have any memberships or affiliations listed. If you are Dr. Carvajal and would like to add memberships or affiliations, please update your profile.

Dr. Carvajal's Reviews

Likelihood of recommending Dr. Carvajal to family and friends
4.1
based on 9 total reviews
Dr. Carvajal's Performance
  • Trustworthiness
    EXCELLENT
  • Explains condition(s) well
    VERY GOOD
  • Answers Questions
    VERY GOOD
  • Time well spent
    EXCELLENT
Office & Staff Performance
  • Scheduling
    EXCELLENT
  • Office environment
    EXCELLENT
  • Staff friendliness
    EXCELLENT
  • Average wait time
    31 to 45 minutes
Have you seen Dr. Richard Carvajal, MD?
Are you Dr. Carvajal?
Make it easy for patients to share their feedback. Also manage your personalized profile!

Visit Dr. Carvajal

Now Accepting New Patients
Dr. Carvajal accepts 19 insurance carriers
  • Aetna
    Choice Plus POS II
  • Amalgamated Clothing & Textile Workers Union
    Amalgamated Clothing & Textile Workers Union WC
  • Amerihealth
  • Blue Cross Blue Shield
    Blue Card PPO
  • Cigna
  • Commercial Insurance Company
  • EBS-RMSCO
  • EmblemHealth
    Emblem Health
    GHI PPO
  • Empire Blue Cross Blue Shield
    Empire Blue Cross Blue Shield HMO
  • Fidelis Care
    Fidelis Care HMO
  • Group Health Cooperative
  • Humana
    Choice Care PPO
  • Locals (any local)
  • MultiPlan
    MultiPlan PPO
    PHCS Network PPO
  • MVP Health Care
  • Oxford Health Plans
    Freedom Plan
  • POMCO Group
  • QualCare
    QualCare HMO
    QualCare PPO
  • UnitedHealthCare
    Choice Plus POS
    Navigate HMO
    Navigate POS
    Options PPO
    Oxford Liberty
    United Healthcare

*Please verify this information when scheduling an appointment.

Hospitals where Dr. Carvajal has admitting privileges

View Hospital Profile
NewYork-Presbyterian/Lawrence Hospital
55 Palmer Ave
Bronxville, NY 10708
View Hospital Profile

More Hematology Specialists like Dr. Carvajal at Columbia University Medical Center Division of Hematology/Oncology

Medical Oncology Specialist
(1)
Hematology Specialist
Medical Oncology Specialist
Hematology Specialist
(1)
Hematology Specialist
(9)
Medical Oncology Specialist